Evidence-Based Recommendations for Opioid Prescribing After Endourological and Minimally Invasive Urological Surgery

被引:13
|
作者
Koo, Kevin [1 ]
Winoker, Jared S. [2 ]
Patel, Hiten D. [3 ]
Faisal, Farzana [2 ]
Gupta, Natasha [2 ]
Metcalf, Meredith R. [2 ]
Mettee, Lynda Z. [2 ]
Meyer, Alexa R. [2 ]
Pavlovich, Christian P. [2 ]
Pierorazio, Phillip M. [2 ]
Matlaga, Brian R. [2 ]
机构
[1] Mayo Clin, Dept Urol, 200 First St SW, Rochester, MN 55905 USA
[2] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA
[3] Loyola Univ Med Ctr, Dept Urol, Maywood, IL USA
关键词
opioids; opioid-related disorders; prescription; endourology; minimally invasive surgery; URETEROSCOPY; FEASIBILITY;
D O I
10.1089/end.2021.0250
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Procedure-specific guidelines for postsurgical opioid use can decrease overprescribing and facilitate opioid stewardship. Initial recommendations were based on feasibility data from limited pilot studies. This study aims to refine opioid prescribing recommendations for endourological and minimally invasive urological procedures by integrating emerging clinical evidence with a panel consensus. Materials and Methods: A multistakeholder panel was convened with broad subspecialty expertise. Primary literature on opioid prescribing after 16 urological procedures was systematically assessed. Using a modified Delphi technique, the panel reviewed and revised procedure-specific recommendations and opioid stewardship strategies based on additional evidence. All recommendations were developed for opioid-naive adult patients after uncomplicated procedures. Results: Seven relevant studies on postsurgical opioid prescribing were identified: four studies on ureteroscopy, two studies on robotic prostatectomy including a combined study on robotic nephrectomy, and one study on transurethral prostate surgery. The panel affirmed prescribing ranges to allow tailoring quantities to anticipated need. The panel noted that zero opioid tablets would be potentially appropriate for all procedures. Following evidence review, the panel reduced the maximum recommended quantities for 11 of the 16 procedures; the other 5 procedures were unchanged. Opioids were no longer recommended following diagnostic endoscopy and transurethral resection procedures. Finally, data on prescribing decisions supported expanded stewardship strategies for first-time prescribing and ongoing quality improvement. Conclusion: Reductions in initial opioid prescribing recommendations are supported by evidence for most endourological and minimally invasive urological procedures. Shared decision-making before prescribing and periodic reevaluation of individual prescribing patterns are strongly recommended to strengthen opioid stewardship.
引用
收藏
页码:1838 / 1843
页数:6
相关论文
共 50 条
  • [41] Postoperative Opioid Prescribing After Female Pelvic Medicine and Reconstructive Surgery
    Reagan, Krista M. L.
    Boyles, Sarah H.
    Brueseke, Taylor J.
    Linder, Brian J.
    Willis-Gray, Marcella G.
    Cichowski, Sara B.
    Long, Jaime B.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (11): : 643 - 653
  • [42] Examining current patterns of opioid prescribing and use after bariatric surgery
    Jordanne Ford
    Tammy Kindel
    Rana M. Higgins
    Kathleen L. Lak
    Emily Hetzel
    Jon C. Gould
    Surgical Endoscopy, 2022, 36 : 2564 - 2569
  • [43] A Systematic Review of Behavioral Interventions to Decrease Opioid Prescribing After Surgery
    Zhang, David D. Q.
    Sussman, Jess
    Dossa, Fahima
    Jivraj, Naheed
    Ladha, Karim
    Brar, Sav
    Urbach, David
    Tricco, Andrea C.
    Wijeysundera, Duminda N.
    Clarke, Hance A.
    Baxter, Nancy N.
    ANNALS OF SURGERY, 2020, 271 (02) : 266 - 278
  • [44] Opioid prescribing patterns and usage after rhinologic surgery: A systematic review
    Zheng, Zhong
    Riley, Charles A.
    Kim, Matthew
    Sclafani, Anthony
    Tabaee, Abtin
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2020, 41 (04)
  • [45] The impact of an enhanced recovery after minimally invasive surgery program on opioid use in gynecologic oncology patients undergoing hysterectomy
    Weston, Erica
    Noel, Margarita
    Douglas, Kara
    Terrones, Kelsey
    Grumbine, Francis
    Stone, Rebecca
    Levinson, Kimberly
    GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 469 - 475
  • [46] Implementing an evidence-based guideline to decrease opioids after cardiac surgery
    Galao-Malo, Roberto
    Davidson, Alison
    D'Aoust, Rita
    Baker, Deborah
    Scott, Mackenzy
    Swain, Julie
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2024, 36 (04) : 241 - 248
  • [47] Reducing Opioid Prescribing After Ambulatory Plastic Surgery With an Opioid-Restrictive Pain Protocol
    Johnson, Shepard P.
    Wormer, Blair A.
    Silvestrini, Rachel
    Perdikis, Galen
    Drolet, Brian C.
    ANNALS OF PLASTIC SURGERY, 2020, 84 : S431 - S436
  • [48] Assessing the impact of procedure-specific opioid prescribing recommendations on opioid stewardship following pelvic organ prolapse surgery
    Linder, Brian J.
    Occhino, John A.
    Wiest, Sheila R.
    Klingele, Christopher J.
    Trabuco, Emanuel C.
    Gebhart, John B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (05) : 515.e1 - 515.e8
  • [49] Predictors of postoperative bleeding after minimally invasive bariatric surgery
    Sebastian, Raul
    Zevallos, Alba
    Cornejo, Jorge
    Sarmiento, Joaquin
    Li, Christina
    Schweitzer, Michael
    Adrales, Gina L.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024, : 7195 - 7201
  • [50] Duration and Magnitude of Opioid Use After Minimally Invasive Sacroiliac Joint Fusion
    Benson, Dillon
    Litvak, Audrey
    Zhang, Douglas
    Johnson, Christopher
    El Dafrawy, Mostafa
    Lee, Michael
    SPINE, 2024, 49 (12) : 857 - 864